Testosterone Deficiency: Clinical Trials

4 trials for Testosterone Deficiency, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting, 1 completed, 1 withdrawn. 4 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 34Recruiting 2, Completed 1, Withdrawn 1
Phase 21Completed 1

Follow Testosterone Deficiency: new trials by email Literature Review of Testosterone Deficiency trials Research Report on Testosterone Deficiency

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Estradiol and Testosterone Subdermal Implants for Menopause Treatment (ESTIME)
testosterone pellet (100 mg), Placebo - Menopause, Testosterone Deficiency
Phase 3RecruitingUniversity of Sao Paulo General Hospital1402025-12-182025-12-29
Does Human Skeletal Muscle Possess an Epigenetic Memory of Testosterone?
Saline, Testosterone Undecanoate, Saline + Resistance exercise training - Healthy Aging, Age-Related Sarcopenia
Phase 2 / Phase 3CompletedNorwegian School of Sport Sciences452024-09-012026-03-06
Impact of Peri-operative tEstosterone Levels on oNcological and Functional Outcomes in RadiCal prostatEctomy
Testosterone gel, Placebo - Prostatic Neoplasms, Hypogonadism
Phase 3RecruitingCanisius-Wilhelmina Hospital1402022-12-122025-05-02
An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal Men
ABT-SLV176 - Hypogonadism, Testosterone Deficiency
Phase 3WithdrawnAbbVie2014-03-012014-06-02

Narrower conditions

Hypogonadism (2)  ·  Prostatic Neoplasms (1)

Broader conditions

Endocrine System Diseases (2)  ·  Gonadal Disorders (2)  ·  Genital Diseases (1)  ·  Genital Diseases, Male (1)  ·  Genital Neoplasms, Male (1)  ·  Male Urogenital Diseases (1)  ·  Neoplasms (1)  ·  Neoplasms by Site (1)  ·  Prostatic Diseases (1)  ·  Urogenital Diseases (1)  ·  Urogenital Neoplasms (1)

Interventions

Sodium Chloride (1)  ·  Testosterone (1)  ·  testosterone undecanoate (1)

Sponsors

AbbVie (1)  ·  Canisius-Wilhelmina Hospital (1)  ·  Norwegian School of Sport Sciences (1)  ·  University of Sao Paulo General Hospital (1)

Countries

Brazil (1)  ·  Netherlands (1)  ·  Norway (1)  ·  United States (1)

Top investigators

Diederik Somford, MD, PhD (1)  ·  Edmund Baracat, PhD (1)  ·  Michael Miller, PharmD (1)

Results publications

PMID 40514343